The Earth's genetic resources of plants and animals exist mainly in the developing South. The Convention on Biological Diversity, which came into force in December 1993, stipulated that if any external party wishes to access these resources it can do so only with the prior consent of the country where they are found. But three-quarters of the botanical gardens, which are mega storehouses, holding samples of as much as half of all vascular plant species in the world, are located in the North. In their quest to discover new sources of plant derived drugs, pharmaceutical giants are now approaching botanical gardens to buy samples of tropical plant diversity. They are finding it easier and more convenient to enter into corporate deals with the gardens than negotiating access with the Southern nations. But in the commercial sale of tropical plants held in Northern botanical gardens, the rights of the countries of their origin arc being ruthlessly sidelined.
We are a voice to you; you have been a support to us. Together we build journalism that is independent, credible and fearless. You can further help us by making a donation. This will mean a lot for our ability to bring you news, perspectives and analysis from the ground so that we can make change together.
Comments are moderated and will be published only after the site moderator’s approval. Please use a genuine email ID and provide your name. Selected comments may also be used in the ‘Letters’ section of the Down To Earth print edition.